Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Study to Measure the Impact of MMprofiler on Treatment Intention in Active Multiple Myeloma Patients

NCT02911571 is registered in ClinicalTrials.gov with SkylineDx as lead sponsor.

NCT NCT02911571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Study to Measure the Impact of MMprofiler on Treatment Intention in Active Multiple Myeloma Patients
Lead sponsor
SkylineDx
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 27, 2018
Completion date
October 1, 2026
Enrollment
250 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma